106 related articles for article (PubMed ID: 10608762)
1. Risk factors for community-acquired pneumonia among persons infected with human immunodeficiency virus.
Navin TR; Rimland D; Lennox JL; Jernigan J; Cetron M; Hightower A; Roberts JM; Kaplan JE
J Infect Dis; 2000 Jan; 181(1):158-64. PubMed ID: 10608762
[TBL] [Abstract][Full Text] [Related]
2. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR;
J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease.
Miguez-Burbano MJ; Ashkin D; Rodriguez A; Duncan R; Pitchenik A; Quintero N; Flores M; Shor-Posner G
Int J Infect Dis; 2005 Jul; 9(4):208-17. PubMed ID: 15916913
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases.
Dworkin MS; Williamson J; Jones JL; Kaplan JE;
Clin Infect Dis; 2001 Aug; 33(3):393-8. PubMed ID: 11438910
[TBL] [Abstract][Full Text] [Related]
6. Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis.
Eigenmann C; Flepp M; Bernasconi E; Schiffer V; Telenti A; Bucher H; Wagels T; Egger M; Furrer H;
Clin Infect Dis; 2003 Apr; 36(7):917-21. PubMed ID: 12652393
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia.
Madden RM; Pui CH; Hughes WT; Flynn PM; Leung W
Cancer; 2007 Apr; 109(8):1654-8. PubMed ID: 17345613
[TBL] [Abstract][Full Text] [Related]
9. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.
Madhi SA; Cutland C; Ismail K; O'Reilly C; Mancha A; Klugman KP
Clin Infect Dis; 2002 Nov; 35(9):1120-6. PubMed ID: 12384847
[TBL] [Abstract][Full Text] [Related]
10. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection.
Schürmann D; Bergmann F; Albrecht H; Padberg J; Wünsche T; Grünewald T; Schürmann M; Grobusch M; Vallée M; Ruf B; Suttorp N
Eur J Clin Microbiol Infect Dis; 2002 May; 21(5):353-61. PubMed ID: 12072919
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality.
Ward MM; Donald F
Arthritis Rheum; 1999 Apr; 42(4):780-9. PubMed ID: 10211894
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
[TBL] [Abstract][Full Text] [Related]
14. Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States.
Fry AM; Facklam RR; Whitney CG; Plikaytis BD; Schuchat A
J Infect Dis; 2003 Sep; 188(5):643-52. PubMed ID: 12934179
[TBL] [Abstract][Full Text] [Related]
15. The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness.
Park DR; Sherbin VL; Goodman MS; Pacifico AD; Rubenfeld GD; Polissar NL; Root RK;
J Infect Dis; 2001 Aug; 184(3):268-77. PubMed ID: 11443551
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of Pneumocystis carinii prophylaxis in patients infected with human immunodeficiency virus: a meta-analysis and decision analysis.
Trikalinos TA; Ioannidis JP
Clin Infect Dis; 2001 Dec; 33(11):1901-9. PubMed ID: 11692302
[TBL] [Abstract][Full Text] [Related]
17. High failure rate of dapsone and pentamidine as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected children.
Nachman SA; Mueller BU; Mirochnick M; Pizzo PA
Pediatr Infect Dis J; 1994 Nov; 13(11):1004-6. PubMed ID: 7845719
[No Abstract] [Full Text] [Related]
18. The prognosis in HIV-infected patients with pneumonia. Relation to microbiological diagnoses.
Jensen BN; Gerstoft J; Skinhøj P
Dan Med Bull; 1991 Dec; 38(6):468-70. PubMed ID: 1666357
[TBL] [Abstract][Full Text] [Related]
19. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.
Jordano Q; Falcó V; Almirante B; Planes AM; del Valle O; Ribera E; Len O; Pigrau C; Pahissa A
Clin Infect Dis; 2004 Jun; 38(11):1623-8. PubMed ID: 15156452
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation among HIV-infected and non-infected adults with community acquired pneumonia in Nairobi.
Mwachari CW; Nduba VN; Park DR; Meier AS; Kariuki JN; Muyodi JA; Karimi F; Kigo A; Holmes KK; Cohen CR
Int J Tuberc Lung Dis; 2006 May; 10(5):516-22. PubMed ID: 16704033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
